Precision Medicine

Understanding Molecular Testing and Treatment for NTRK Fusions

Martin F. Dietrich, MD, PhD
Managing Acquired ESR1 Resistance Mutations in Advanced HR+ Breast Cancer

Adrienne G. Waks, MD
Implementing HER2-Targeted Strategies for the Treatment of Biliary Tract Cancers

John Strickler, MD; Tanios S. Bekaii-Saab, MD
Targeting KRAS: Beyond KRAS G12C

John Strickler, MD
Blood-Based Testing to Detect Genomic Amplification: Lessons from HER2

John Strickler, MD
Targeting MTAP Loss: Preliminary Data for an Emerging Target

John Strickler, MD
Targeting KRAS G12C: Focus on Lung Cancer and GI Malignancies

Charu Aggarwal, MD, MPH; John Strickler, MD
Unmasking Resistance: Rising ctDNA and ESR1 Mutation in Early-Stage HR+ Breast Cancer

Jason A. Mouabbi, MD
NRG1 Fusions: The Newest Actionable Target

John Strickler, MD
c-Met as an Emerging Target in Advanced Colorectal Cancer

John Strickler, MD
c-MET as an Emerging Target in Advanced Lung Cancer

Charu Aggarwal, MD, MPH
Evolving Management of HER2 Low and Ultralow Breast Cancer

Adrienne G. Waks, MD